Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06501937 · ClinicalTrials.gov registry record · NA
Influencer Marketing: a Survey-based Experiment Among Adolescents
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 664
- Enrollment target
NCT06501937: Completed NA study, sponsored by University of Southern California.
NCT06501937 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 664 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06501937, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 664 participants
- Enrollment target
Study Summary
Adolescents (N = 664) participated in the online survey-based experiment. They were randomly shown 10 videos, featuring influencers promoting e-cigarettes alongside healthy lifestyle activities (experimental group), or e-cigarette promotion alone (control). After watching each video, participants rated perceptions of influencer credibility (i.e., honesty, trustworthiness, knowledge) on the scale of 0 (e.g., dishonest) to 100 (honest). Among all participants, harm perceptions and appeal of e-cigarettes was assessed. Susceptibility to use e-cigarettes was assessed among never users of e-cigarettes. These outcomes were then compared among participants who perceived influencers as credible and those who perceived influencers as non-credible.
Primary Outcome
Responses to two questions adapted from PATH, "Based on the videos you just watched, do you think using e-cigarettes for vaping nicotine is harmful to your health?" "Based on the videos you just watched, do you think people harm themselves when they use e-cigarettes for vaping nicotine?" Outcome was assessed on the 0 (Not harmful at all) - 100 (Very harmful) scale. Since the items were closely related (α=0.87), they were combined (by summing all the non-missing values of the items) into one vari
Interventions
- OTHER Influencer marketing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 664 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
What the finished NCT06501937 record still lists
NCT06501937 is an interventional study that assigns participants to a tested intervention. The registered 664 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Influencer marketing is the first listed.
NCT06501937 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06501937 about?
NCT06501937 is a clinical study titled "Influencer Marketing: a Survey-based Experiment Among Adolescents". Adolescents (N = 664) participated in the online survey-based experiment. They were randomly shown 10 videos, featuring influencers promoting e-cigarettes alongside healthy lifestyle activities (experimental group), or e-cigarette promotion alone (control). After watching each video, participants ra...
What is the current status of trial NCT06501937?
This trial is currently completed. It is a NA study. The enrollment target is 664 participants. The study started on 2024-02-12. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT06501937?
The interventions under investigation include: Influencer marketing (OTHER).
Who is sponsoring clinical trial NCT06501937?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06501937's enrollment target sits among peer trials
664 155th of 2000 higher than 1,846 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06607341 · 664 participants · NA
Community Engagement Alliance Against Disparities
- NCT04064060 · 665 participants · Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- NCT07164443 · 663 participants · Phase 3
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- NCT06328647 · 666 participants · NA
Quantra Point-of-Care Hemostasis Monitoring
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI